In Vitro and In Vivo Activities of Antimicrobials against Nocardia brasiliensis

AUTOR(ES)

Gomez-Flores, Alejandra

FONTE

American Society for Microbiology

RESUMO

In Mexico mycetomas are mostly produced by Nocardia brasiliensis, which can be isolated from about 86% of cases. In the present work, we determined the sensitivities of 30 N. brasiliensis strains isolated from patients with mycetoma to several groups of antimicrobials. As a first screening step we carried out disk diffusion assays with 44 antimicrobials, including aminoglycosides, cephalosporins, penicillins, quinolones, macrolides, and some others. In these assays we observed that some antimicrobials have an effect on more than 66% of the strains: linezolid, amikacin, gentamicin, isepamicin, netilmicin, tobramycin, minocycline, amoxicillin-clavulanic acid, piperacillin-tazobactam, nitroxolin, and spiramycin. Drug activity was confirmed quantitatively by the broth microdilution method. Amoxicillin-clavulanic acid, linezolid, and amikacin, which have been used to treat patients, were tested in an experimental model of mycetoma in BALB/c mice in order to validate the in vitro results. Linezolid showed the highest activity in vivo, followed by the combination amoxicillin-clavulanic acid and amikacin.

Documentos Relacionados

• In Vitro Activities of New Antimicrobials against Nocardia brasiliensis
• In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas
• In Vitro Activities of Linezolid against Multiple Nocardia Species
• In Vitro Comparison of Activities of Terbinafine and Itraconazole against Paracoccidioides brasiliensis
• Comparative In Vitro Activities of Gemifloxacin, Other Quinolones, and Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria